spacer
home > ict > Winter 2008
PUBLICATIONS

International Clinical Trials

ict
Winter 2008
At the cutting edge of the latest industry developments, Samedan is adept at keeping the information you need at your fingertips. ICT provides a unique platform of communication for the market across Europe, North America and the rest of the developed world. To find out what's hot in the world of pharmaceuticals, take a look below at the range of articles featured in this issue of ICT
   
Text
PDF
bullet
Clinical Trial Management
As the pharma industry struggles to cope with the high rate of Phase III failures, Mike Macnamee of LCG Bioscience believes that it is crucial to use patients in the early stages of clinical research in order to grasp the opportunities created by more personalised and gene-specific therapeutics, in Patients Are a Virtue  
view
download pdf
Kenneth Getz at the Tufts Center for the Study of Drug Development, James Kremidas at Eli Lilly and Company, Elizabeth Carfioli of Ogilvy Healthworld Consulting (US) and Rachael Butlin at Fast4wD Ogilvy (UK) pursue ways in which to challenge and improve public perceptions of clinical research, in We Can be Heroes  
view
download pdf
In New Waves, Dr Timothy Callahan and Dr Pierre Maison-Blanche of Biomedical Systems put the spotlight on comprehensive training at investigative sites – a necessary step for ensuring that ECG data collected onsite is of a high quality, free of artifact and has minimal variability  
view
download pdf
Bruce Stouch at Premier Research explores the construct of asymmetrical boundaries for interim monitoring of a fixed design, as well as the design requirements for monitoring using a Bayesian approach, in Monitored Progress  
view
download pdf
bullet
eCLINICAL
Secure, private and of higher quality than paper diary records, eDiaries have finally entered the mainstream. In Regulating e-Diaries, Valdo Arnera and Stephen A Raymond of PHT Corporation reflect on the key regulations affecting eDiary systems and how their providers and sponsors should adhere to these rules  
view
download pdf
In Pharma Champion, Mark Penniston at Omnicare Clinical Research General notes that acceptance of CDISC has gained momentum over the past few years and has a very strong future, especially as regulatory bodies increase their usage of these standards  
view
download pdf
Clinical trials frequently rely on subjective clinician-rated outcomes as pivotal endpoints – thus missing out on electronic tools which can assist in reinforcing continuous data reliability. In Improving Ratings Precision, Oto Markovic and Rusty Bealer of United BioSource Corporation examine how these systems can be designed and deployed in support of clinical trials  
view
download pdf
bullet
Drug delivery & Therapeutics
Over the past year revenues from global clinical trials have increased by almost 15 per cent. Gary Muddyman of Conversis unpicks the Cultural Dimensions of running trials in emerging markets, outlining the need to avoid stumbling blocks such as differing clinical trial demands in disparate locales, varied sales and distribution channels, the coordination of simultaneous launches to market, and drug cloning and counterfeiting  
view
download pdf
Having overcome a recent spot of trouble, Russia’s role in the development of international clinical trials in Central and Eastern Europe looks increasingly promising; whilst the emergence of Ukraine, Belarus and Kazakhstan in the trials arena in 2008 will be one to watch out for, opines Irina Dobreva of Congenix in Research Reaches Beyond Borders  
view
download pdf
Shifting pharmacovigilance and clinical data management work abroad is allowing pharmaceutical firms to maximise R&D and push drugs to market more effectively – Charles Arnold and Vicki Tauscher Phelan of EquaTerra investigate The New Frontier in outsourcing  
view
download pdf
bullet
Labs & Logistics
In The Power of Communication, Mark Woolf of Almac Clinical Services explores the complex challenges faced by distribution managers surrounding the shipping of clinical trials materials to emerging markets  
view
download pdf
The temperature-sensitive nature of numerous drugs and the importance of achieving reliable test results make it particularly important that drugs arrive at their destination with their integrity intact. Geraint Thomas of Laminar Medica points to the advantages of careful planning and investment in the latest technology during shipping, in The Trials of Temperature Control  
view
download pdf
   
spacer
Edited by
Dr Graham Hughes
Consultant in
Pharmaceutical
Development

Published quarterly in
February, May,
August and November

News and Press Releases

Oxford Genetics licenses SnapFast™ expression vectors to Twist Bioscience

November 16, 2017, Oxford, England and San Francisco, US. – Oxford Genetics, a leader in innovative synthetic biology-based technologies for biologics discovery, development and delivery, announced today a new licensing agreement with Twist Bioscience Corporation, a company enabling customers to succeed through its offering of rapid, high-quality synthetic DNA. Oxford Genetics will supply Twist Bioscience with its SnapFast™ technology platform to provide a broad range of application-specific expression vectors which Twist Bioscience will use to clone synthesized DNA for its diverse customer base.
More info >>

White Papers

Personalised Medicine - Pharma and Dx Firms Share Wider Horizons

DiagnostikNet-BB

Personalised medicine might be a popular catch-phrase at the moment, but the term often causes confusion, as there is still no uniform definition for it. The expression can include areas as diverse as the measurement of individual risk, early detection using biomarker testing, stratification of patients suffering from a disease and predictions about its course.
More info >>

Industry Events

Drug Discovery 2018

21-22 March 2018, Copthorne Tara Hotel, Scarsdale Place, Kensington, London

SMi Group is proud to announce the return of Drug Discovery in 2018. The successful conference will return for its 2nd year on the 21st and 22nd March.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement